Wordt geladen...
Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy
Probenecid has been used for decades in the treatment of gout but recently has also been found to improve outcomes in patients with heart failure via stimulation of the transient receptor potential vanilloid 2 (TRPV2) channel in cardiomyocytes. This study tested the use of probenecid on a novel mous...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100971/ https://ncbi.nlm.nih.gov/pubmed/32218573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0230386 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|